Skip to main content
. 2013 Feb 1;3:1196. doi: 10.1038/srep01196

Figure 3. Spleen tissue of an Il6rahIL6R/hIL6R mouse (a, d), an Il6rahIL6R/hIL6R-hIL6 transgenic mouse (b, e), and a tocilizumab-treated Il6rahIL6R/hIL6R-hIL6 transgenic mouse (c, f).

Figure 3

Increase of plasma cells and increased numbers of white pulp in the Il6rahIL6R/hIL6R-hIL6 transgenic mouse (b, e) were ameliorated after 4-week treatment with tocilizumab (c, f). Plasma cells are shown in insert (b). Bars: (a–c), 100 μm; (d–f), 500 μm. W, white pulp.